Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
6
Bullish
4
Bearish
19
Neutral
6
Bullish
21
Bearish
15
Neutral
0
Bullish
17
Bearish
4
Neutral
6
Bullish
4
Bearish
4
Neutral
6
Bullish
4
Bearish
15
Neutral
0
Bullish
17
Bearish
15
Neutral
0
Bullish
17
Bearish
15
Neutral
0
Bullish
17
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q1 FY27
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Discovery themes featuring this stock
Godavari Biorefineries Limited is an integrated bio-refinery operating across sugar, ethanol, bio-based specialty chemicals, co-generation power and a consumer foods brand, combining upstream sugarcane farming linkages with downstream chemical manufacturing and branded retail distribution to serve industrial and consumer markets.
Financially, Q3 FY26 showed modest revenue growth (Total Income Rs. 461.9 crore, +2.5% YoY) while profitability improved materially: Q3 EBITDA rose to Rs. 45.1 crore (+13.8% YoY) and finance costs fell ~46% after repayment of Rs. 240 crore term debt funded by IPO proceeds, improving earnings quality and cash costs.
Godavari is executing a deliberate portfolio shift toward higher‑margin specialty chemicals where the specialty share rose to ~62% of the chemicals mix and segment margins expanded meaningfully (Q3 chemical EBITDA margin to 7.7% and 9M margin to 8.9%), signalling product mix transformation driving margin expansion.
The company is advancing multiple innovation platforms: a CO2-to-DME pilot with ICT Mumbai, a commercialization collaboration with Synthomer for bio-based butyl acrylate, and an oncology IP programme via a US subsidiary with a granted US patent and completed Phase I safety trials, showing diversification beyond commodity cycles.
Consumer brand Jivana reached ~Rs.100 crore revenue in 9M FY26, expanded retail reach to over 7,500 outlets and reported strong e-commerce traction (Zepto growth cited as 15x), indicating Godavari is building a stable, cash-generating branded channel alongside industrial operations.
Diversified FMCG
Diversified FMCG
1,229 Cr
Moderate Risk
5,586.3
25.6
-0.1
1.6
353.50
224.00
Sales CAGR
Profit CAGR
ROE
ROCE
Godavari Biorefineries Ltd (GODAVARIB) is currently trading at 243.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Godavari Biorefineries Limited is an integrated bio-refinery operating across sugar, ethanol, bio-based specialty chemicals, co-generation power and a consumer foods brand, combining upstream sugarcane farming linkages with downstream chemical manufacturing and branded retail distribution to serve industrial and consumer markets. Financially, Q3 FY26 showed modest revenue growth (Total Income Rs. 461.9 crore, +2.5% YoY) while profitability improved materially: Q3 EBITDA rose to Rs. 45.1 crore (+13.8% YoY) and finance costs fell ~46% after repayment of Rs. 240 crore term debt funded by IPO proceeds, improving earnings quality and cash costs. Godavari is executing a deliberate portfolio shift toward higher‑margin specialty chemicals where the specialty share rose to ~62% of the chemicals mix and segment margins expanded meaningfully (Q3 chemical EBITDA margin to 7.7% and 9M margin to 8.9%), signalling product mix transformation driving margin expansion. The company is advancing multiple innovation platforms: a CO2-to-DME pilot with ICT Mumbai, a commercialization collaboration with Synthomer for bio-based butyl acrylate, and an oncology IP programme via a US subsidiary with a granted US patent and completed Phase I safety trials, showing diversification beyond commodity cycles. Consumer brand Jivana reached ~Rs.100 crore revenue in 9M FY26, expanded retail reach to over 7,500 outlets and reported strong e-commerce traction (Zepto growth cited as 15x), indicating Godavari is building a stable, cash-generating branded channel alongside industrial operations.
Over the past 52 weeks, Godavari Biorefineries Ltd has traded between a low of ₹224.00 and a high of ₹353.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Godavari Biorefineries Ltd has a market capitalization of approximately 1,228.99. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Godavari Biorefineries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 5586.32 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,228.99 Cr, Godavari Biorefineries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Godavari Biorefineries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Godavari Biorefineries Ltd is 5586.32. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The results are expected in the July-August 2026 window for the quarter ended June 2026, in line with the broader results season.
They are expected in the July-August 2026 window, as indicated in the preview.
The stock rose after the company announced that the Japan Patent Office granted a patent for its invention, 5-Hydroxy-1,4-naphthalenedione, for use in cancer treatment.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
243.00 | 1,229 Cr | 5586.32 | 1.56 | 0.00 | 4.27 | 6.38 | 0.01 | ||
536.85 | 1,201 Cr | 42.23 | 8.09 | 0.00 | 19.16 | 25.71 | 16.53 | ||
2.08 | 351 Cr | 43.13 | 0.79 | 0.00 | 1.69 | 4.73 | 0.97 | ||
238.85 | 339 Cr | 26.02 | 4.65 | 0.00 | 15.92 | 19.07 | 12.72 | ||
268.70 | 188 Cr | 17.45 | 1.43 | 0.00 | 9.74 | 9.68 | 7.71 | ||
15.70 | 11 Cr | 7.97 | 0.46 | 0.00 | 5.58 | 7.58 | 5.12 | ||
3.55 | 2 Cr | -26.62 | 0.00 | 0.00 | 0.48 | -1.86 | -1.37 | ||
| Median: 7 Co. | — | 238.85 | 339 Cr | 26.02 | 1.43 | 0.00 | 5.58 | 7.58 | 5.12 |
